References
1. Chow WH, Devesa SS, Warren JL, et al. Rising incidence of renal cell
cancer in the United States. J Am Med Assoc 1999; 281:17-1628.
2. Ferlay J, Foucher ES, Tieulent JL, et al. Cancer incidence and
mortality patterns in Europe: Estimates for 40 countries in 2012. Eur.
J. Cancer 2013; 49:6-1374.
3. Haferkamp A, Bastian PJ, Jakobi H, et al. Renal cell carcinoma with
tumor thrombus extension ınto the vena cava: Prospective long-term . J
Urol 2007; 177:5-1703.
4. Berg AA. Malignant hypernephroma of the kidney, its clinical course,
and diagnosis, with a description of the author’s method of radical
operative cure. Surg Gynecol Obs 1913; 17:446-71.
5. Rigaud J, Hetet JF, Braud G, et al. Surgical care, morbidity,
mortality and after nephrectomy for renal cancer with extension of tumor
thrombus into the ınferior vena cava: Retrospective study since 1990s.
Eur Urol 2006; 50:2-302.
6. Zisman A, Wieder JA, Pantuck AJ, et al. Renal cell carcinoma with
tumor thrombus extension: Biology, role of nephrectomy and response to
immunotherapy. J Urol 2003; 169:3-909.
7. Cao C, Bi X, Liang J, et al. Long-term survival and prognostic
factors for locally advanced renal cell carcinoma with renal vein tumor
thrombus. BMC Cancer 2019; 19:1-144.
8. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a
combined comorbidity index. J Clin Epidemiol 1994; 47:11-1245.
9. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria
of the Eastern Cooperative Oncology Group. Am J of Clin Oncol 1982;
5:6-649.
10. Blute ML, Leibovich BC, Lohse CM, et al. The Mayo Clinic experience
with surgical management, complications and outcome for patients with
renal cell carcinoma and venous tumor thrombus. BJU Int 2004; 94:1-33.
11. Wolters U, Wolf T, Stützer H, et al. ASA classification and
perioperative variables as predictors of postoperative outcome. Br J
Anaesth 1996; 77:2-217.
12. Dindo D, Demartines N, Clavien PA. Classification of surgical
complications: A new proposal with evaluation in a cohort of 6336
patients and results of a survey. Annals of Surgery 2004; 240:2-205.
13. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th
Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann of
Surg Oncol 2010;17-1471.
14. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of
morphologic parameters in renal cell carcinoma. The Am J of Surg Oncol
1982; 6:7-655.
15. Beisland C, Guðbrandsdottir G, Reisæter LAR. A prospective
risk-stratified follow-up programme for radically treated renal cell
carcinoma patients: Evaluation after eight years of clinical use. World
J Urol 2016; 34:8-1087.
16. Mager R, Daneshmand S, Evans CP, et al. Renal cell carcinoma with
inferior vena cava involvement: Prognostic effect of tumor thrombus
consistency on cancer specific survival. J Surg Oncol 2016; 114:6-764.
17. Skinner DG, Pritchett TR, Lieskovsky G, et al. Vena caval
involvement by renal cell carcinoma: Surgical resection provides
meaningful long-term survival. Ann Surg 1989; 210:3-387.
18. Zhu H, Wang Q, Wang M. Surgical management of renal cell carcinoma
extending into venous system: A 20-year experience. Scand J Surg 2018;
107:2-158.
19. Ciancio M, Manoharan M, Katkoori D, et al. Long-term survival in
patients undergoing radical nephrectomy and inferior vena cava
thrombectomy: Single-center experience. Eur Urol 2010; 57:4-667.
20. Méjean A, Ravaud A, Thezenas S, et al. Sunitinib alone or after
nephrectomy in metastatic renal-cell carcinoma. N Engl J Med 2018;
379:5-417.
21. Bex A, Mulders P, Jewett M, et al. Comparison of ımmediate vs
deferred cytoreductive nephrectomy in patients with synchronous
metastatic renal cell carcinoma receiving sunitinib: The SURTIME
randomized clinical trial. JAMA Oncology 2019; 5:2-164.
22. Rabbani F, Hakimian P, Reuter VE, et al. Renal vein or inferior vena
caval extension in patients with renal cortical tumors: Impact of tumor
histology. J Urol 2004; 171:3-1057.
23. Agochukwu N, Shuch B. Clinical management of renal cell carcinoma
with venous tumor thrombus. World J Urol 2014; 32:3-581.
24. Wagner B, Patard JJ, Mejean A, et al. Prognostic value of renal vein
and ınferior vena cava involvement in renal cell carcinoma. Eur Urol
2009; 55:2-452.
25. Choi DK, Jeon HG, Jeong CW, et al. Surgical treatment of renal cell
carcinoma: Can morphological features of inferior vena cava tumor
thrombus on computed tomography or magnetic resonance imaging be a
prognostic factor? Int J Urol; 24:2-102.
26. Al Otaibi M, Youssif TA, Alkhaldi A, et al. Renal cell carcinoma
with inferior vena caval extension: Impact of tumor extent on surgical
outcome. BJU Int 2009;104:10-1467.
27. Berczi A, Flasko T, Szerafin T, et al. Surgical management and
outcome of renal cell carcinoma with ınferior vena cava tumor thrombus.
Urol Int 2017; 99:3-267.
28. Glazer AA, Novick AC. Long-term follow-up after surgical treatment
for renal cell carcinoma extending into the right atrium. J Urol 1996;
155:2-448.
29. Frank I, Blute ML, Cheville JC, et al. An outcome prediction model
for patients with clear cell renal cell carcinoma treated with radical
nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN
score. J Urol 2002; 168:6-2395.